Nyxoah S.A. provided earnings guidance. Company expected a strong year-over-year growth in the first quarter, company anticipate sales to be down sequentially.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
7.34 EUR | +4.86% |
|
+11.55% | +72.30% |
07-03 | Nyxoah Secures $40 Million Loan Facility from European Investment Bank | MT |
07-01 | Nyxoah Submits Final Module of Premarket Approval Application for Sleep Apnea Therapy to FDA | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.30% | 260M | |
+0.91% | 204B | |
+3.74% | 178B | |
+28.89% | 154B | |
+31.66% | 112B | |
+1.14% | 64.16B | |
+19.45% | 54.88B | |
-3.44% | 46.69B | |
-9.28% | 36.8B | |
-0.10% | 35.26B |
- Stock Market
- Equities
- NYXH Stock
- News Nyxoah SA
- Nyxoah S.A. Provides Earnings Guidance for the First Quarter of 2024